|
|
|||
|
Date: Monday, June 24, 2013 - 8:00 am
|
||
|
|||
|
SMi Presents the 3rd Annual conference: SMi’s 3rd Annual Biobanking conference will aim to bring together key solution providers and potential clients affiliated with pharmaceutical companies and Biobanking institutions alike. As researchers endeavour to develop more personalised medicines, acquiring high quality biospecimens is essential. This is reflected in the estimation that the global Biobanking market is expected to reach $183 billion as biobanks experience rapid growth. SMi’s 3rd annual Biobanking event will reflect the significant change driving current development in biosample management. There will be efforts to associate value to existing biological resources and coverage of important issues experienced by those who donate, manage and expend biobank samples. Focussing on the properties of data sharing and greater involvement between biobanks, allow Biobanking 2013 to give you the most recent up to date information on Biobanking today. Benefits of Attending:
The first 2 instalments in the Biobanking series received great feedback from the industry. Comments included Roche – “‘‘Entertaining and informative’’, Merck - ‘‘Stimulated, good discussions and provided good feedback on questions’’ and GSK - ‘‘Detailed and specific’’ To attend contact Jonathan Collins on Tel +44 (0)20 7827 6734 Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it Register Online at |
|||
|
||
| Home | Calendar of Events | Services | News | Resources | Products | Contact | Directory Search | Partner with Us | Media Partners | Link to Us | Terms of Use |
© 2019 Bioscreening.com